Koers Shanghai Allist Pharmaceuticals Co., Ltd.
Aandelen
688578
CNE100005XJ7
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
59,6 CNY | +0,03% | -7,78% | +43,06% |
Omzet 2024 * | 2,96 mld. 410 mln. 377 mln. | Omzet 2025 * | 3,45 mld. 478 mln. 440 mln. | Marktkapitalisatie | 26,82 mld. 3,71 mld. 3,42 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,04 mld. 144 mln. 132 mln. | Nettowinst (verlies) 2025 * | 1,22 mld. 169 mln. 155 mln. | EV/omzet 2024 * | 9,06 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 7,76 x |
K/w-verhouding 2024 * |
25,9
x | K/w-verhouding 2025 * |
22
x | Werknemers | 1.044 |
Dividendrendement 2024 * |
0,84% | Dividendrendement 2025 * |
0,84% | Vrij verhandelbaar | 34,03% |
1 dag | +0,03% | ||
1 week | -7,78% | ||
Lopende maand | -3,99% | ||
1 maand | +29,37% | ||
3 maanden | +42,99% | ||
6 maanden | +62,84% | ||
Lopend jaar | +43,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jin Hao Du
CEO | Chief Executive Officer | 70 | 22-03-04 |
Feng Xu
BRD | Director/Board Member | 59 | 01-01-17 |
Jie Hu
BRD | Director/Board Member | 49 | 25-06-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jun Yan
BRD | Director/Board Member | 42 | 28-11-19 |
Jin Hao Du
CEO | Chief Executive Officer | 70 | 22-03-04 |
Rong Gang Xie
BRD | Director/Board Member | 39 | 28-11-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-05-24 | 59,6 | +0,03% | 4 352 033 |
16-05-24 | 59,58 | -1,42% | 5 118 090 |
15-05-24 | 60,44 | -0,67% | 5 941 320 |
14-05-24 | 60,85 | -1,47% | 6 506 604 |
13-05-24 | 61,76 | -3,71% | 10 498 960 |
slotkoers Shanghai S.E., 17 mei 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,06% | 3,71 mld. | |
+9,42% | 114 mld. | |
+11,84% | 104 mld. | |
-14,15% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,16% | 17,89 mld. | |
+7,99% | 14,28 mld. | |
+36,24% | 12,55 mld. |